These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22126431)

  • 1. Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome.
    Norheim KB; Jonsson G; Harboe E; Hanasand M; Gøransson L; Omdal R
    Free Radic Res; 2012 Feb; 46(2):141-6. PubMed ID: 22126431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of advanced oxidation protein products in plasma.
    Hanasand M; Omdal R; Norheim KB; Gøransson LG; Brede C; Jonsson G
    Clin Chim Acta; 2012 May; 413(9-10):901-6. PubMed ID: 22336637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
    Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
    J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonin in primary Sjögren's syndrome: level and relation with disease activity.
    Sarac H; Markeljevic J; Mokrovic G; Erdeljic V; Bozina N; Cicin-Sain L
    J Neuroimmunol; 2012 Oct; 251(1-2):87-9. PubMed ID: 22819441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
    Zheng L; Yu C; Zhang Z; Yang C; Cai X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
    Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
    Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
    Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
    Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
    Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
    Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary resistin reflects local inflammation in Sjögren's syndrome.
    Boström EA; d'Elia HF; Dahlgren U; Simark-Mattsson C; Hasséus B; Carlsten H; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 Oct; 35(10):2005-11. PubMed ID: 18709689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP).
    Veyseller B; Aksoy E; Ertaş B; Keskin M; Ozturan O; Yildirim YS; Bayraktar EG; Oztürk H
    B-ENT; 2010; 6(2):105-9. PubMed ID: 20681362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
    De CR; Rocca B; Marchioli R; Landolfi R
    Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.
    Liu MF; Lin LH; Weng CT; Weng MY
    Lupus; 2008 Jan; 17(1):34-9. PubMed ID: 18089681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
    Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased advanced oxidation of protein products and enhanced total antioxidant capacity in plasma by action of toxins of Escherichia coli STEC.
    Aiassa V; Baronetti JL; Paez PL; Barnes AI; Albrecht C; Pellarin G; Eraso AJ; Albesa I
    Toxicol In Vitro; 2011 Feb; 25(1):426-31. PubMed ID: 21092753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
    Vriezekolk JE; Geenen R; Hartkamp A; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
    J Rheumatol; 2005 Dec; 32(12):2351-5. PubMed ID: 16331762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome.
    Ryo K; Yamada H; Nakagawa Y; Tai Y; Obara K; Inoue H; Mishima K; Saito I
    Pathobiology; 2006; 73(5):252-60. PubMed ID: 17314496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.
    Baturone R; Soto MJ; Márquez M; Macías I; de Oca MM; Medina F; Chozas N; García-Pérez S; Girón-González JA
    Scand J Rheumatol; 2009; 38(5):386-9. PubMed ID: 19575332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.